| |
| |
|
| Insider
Information: |
Wee Wendy |
| Relationship: |
Chief Financial Officer |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
22,273 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$512 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
22,273 |
|
|
| Total
Value |
$512 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mabvax Therapeutics Holdings Inc |
MBVX |
Officer |
2010-12-22 |
22,273 |
|
0 |
Premium* |
|
|
Kindred Biosciences, Inc. |
KIN |
Chief Financial Officer |
2021-08-27 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KIN |
Kindred Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-08-27 |
4 |
D |
$9.25 |
$727,170 |
D/D |
(78,613) |
0 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-01-23 |
4 |
D |
$4.93 |
$16,688 |
D/D |
(3,385) |
49,039 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-01-22 |
4 |
D |
$4.93 |
$20,026 |
D/D |
(4,062) |
52,424 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-01-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
56,486 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-01-17 |
4 |
D |
$4.95 |
$16,756 |
D/D |
(3,385) |
48,968 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,250 |
52,371 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-01-23 |
4 |
D |
$9.66 |
$20,721 |
D/D |
(2,145) |
44,121 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-01-22 |
4 |
D |
$9.88 |
$24,305 |
D/D |
(2,460) |
46,266 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-01-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
48,726 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Financial Officer |
• – – |
2019-01-23 |
4 |
D |
$9.95 |
$21,262 |
D/D |
(2,138) |
38,827 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Financial Officer |
• – – |
2019-01-22 |
4 |
D |
$10.12 |
$28,012 |
D/D |
(2,768) |
40,965 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Financial Officer |
• – – |
2019-01-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
43,733 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Financial Officer |
• – – |
2018-01-23 |
4 |
D |
$9.15 |
$20,880 |
D/D |
(2,282) |
30,718 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Financial OfficerOfficer |
• – – |
2017-07-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
33,000 |
|
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
Principal Financial Officer & |
• – – |
2010-12-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
22,273 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
